ZA938171B - Conjugate vaccine against group B Streptococcus. - Google Patents
Conjugate vaccine against group B Streptococcus.Info
- Publication number
- ZA938171B ZA938171B ZA938171A ZA938171A ZA938171B ZA 938171 B ZA938171 B ZA 938171B ZA 938171 A ZA938171 A ZA 938171A ZA 938171 A ZA938171 A ZA 938171A ZA 938171 B ZA938171 B ZA 938171B
- Authority
- ZA
- South Africa
- Prior art keywords
- streptococcus
- vaccine against
- conjugate vaccine
- against group
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96886692A | 1992-11-02 | 1992-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA938171B true ZA938171B (en) | 1995-03-07 |
Family
ID=25514876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA938171A ZA938171B (en) | 1992-11-02 | 1993-11-02 | Conjugate vaccine against group B Streptococcus. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0669985A1 (en) |
JP (1) | JPH08505282A (en) |
KR (1) | KR100349331B1 (en) |
AU (1) | AU689452B2 (en) |
CA (1) | CA2146926A1 (en) |
FI (1) | FI951979A (en) |
HU (1) | HU220198B (en) |
IL (1) | IL107458A0 (en) |
NO (1) | NO951629L (en) |
NZ (1) | NZ258684A (en) |
PL (1) | PL177302B1 (en) |
RU (1) | RU2209247C2 (en) |
WO (1) | WO1994010317A2 (en) |
ZA (1) | ZA938171B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6015889A (en) * | 1993-03-19 | 2000-01-18 | Gunnar Lindahl | Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
US6284884B1 (en) | 1995-06-07 | 2001-09-04 | North American Vaccine, Inc. | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
EP1100920A2 (en) * | 1998-07-27 | 2001-05-23 | Microbial Technics Limited | Nucleic acids and proteins from group b streptococcus |
US7098182B2 (en) | 1998-07-27 | 2006-08-29 | Microbial Technics Limited | Nucleic acids and proteins from group B streptococcus |
US6890539B2 (en) | 1998-12-22 | 2005-05-10 | Microscience, Ltd. | Genes and proteins, and their use |
KR100866170B1 (en) * | 1998-12-22 | 2008-10-30 | 이머전트 프로덕트 디벨로프먼트 유케이 리미티드 | Outer surface proteins, their genes and their use |
GB9910375D0 (en) | 1999-05-05 | 1999-06-30 | Lindahl Gunnar | Vaccine composition |
ES2382893T3 (en) * | 2000-10-13 | 2012-06-14 | Id Biomedical Corporation | BVH-A2 and BVH-3 antigens of group B streptococcus |
AU2004220590B2 (en) | 2003-03-07 | 2010-02-18 | Inhibitex, Inc. | Polysaccharide - Staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
CN101855238B (en) | 2007-04-16 | 2014-09-17 | 米纳瓦克斯有限责任公司 | Fusion protein vaccine |
WO2010022961A1 (en) * | 2008-08-28 | 2010-03-04 | Novartis Ag | Cell surface display of polypeptide isoforms by stop codon readthrough |
CA3001433A1 (en) | 2015-10-21 | 2017-04-27 | Minervax Aps | Immunogenic fusion protein |
WO2017114655A1 (en) | 2015-12-30 | 2017-07-06 | Minervax Aps | Immunogenic complex for eliciting protective immunity against group b streptococcus |
CA3066020A1 (en) | 2017-06-16 | 2018-12-20 | Glaxosmithkline Biologicals Sa | Method of treatment |
EP4061412A1 (en) | 2019-11-22 | 2022-09-28 | GlaxoSmithKline Biologicals S.A. | Dosage and administration of a bacterial saccharide glycoconjugate vaccine |
EP4066854A1 (en) | 2021-03-29 | 2022-10-05 | MinervaX | Immunogenic fusion protein |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0302887B1 (en) * | 1986-04-16 | 1994-06-22 | The Brigham And Women's Hospital, Inc. | Bacterial antigens, antibodies, vaccines, and methods of manufacture |
IL95578A (en) * | 1989-09-15 | 1998-08-16 | Gen Hospital Corp | Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus |
-
1993
- 1993-11-01 IL IL10745893A patent/IL107458A0/en unknown
- 1993-11-02 WO PCT/US1993/010506 patent/WO1994010317A2/en not_active Application Discontinuation
- 1993-11-02 PL PL93308555A patent/PL177302B1/en not_active IP Right Cessation
- 1993-11-02 ZA ZA938171A patent/ZA938171B/en unknown
- 1993-11-02 CA CA002146926A patent/CA2146926A1/en not_active Abandoned
- 1993-11-02 NZ NZ258684A patent/NZ258684A/en unknown
- 1993-11-02 KR KR1019950701811A patent/KR100349331B1/en not_active IP Right Cessation
- 1993-11-02 HU HU9501260A patent/HU220198B/en not_active IP Right Cessation
- 1993-11-02 RU RU95113472/13A patent/RU2209247C2/en not_active IP Right Cessation
- 1993-11-02 AU AU56654/94A patent/AU689452B2/en not_active Ceased
- 1993-11-02 EP EP94902202A patent/EP0669985A1/en not_active Withdrawn
- 1993-11-02 JP JP6511389A patent/JPH08505282A/en active Pending
-
1995
- 1995-04-26 FI FI951979A patent/FI951979A/en not_active Application Discontinuation
- 1995-04-28 NO NO951629A patent/NO951629L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU5665494A (en) | 1994-05-24 |
EP0669985A1 (en) | 1995-09-06 |
HUT70981A (en) | 1995-11-28 |
IL107458A0 (en) | 1994-02-27 |
WO1994010317A2 (en) | 1994-05-11 |
NZ258684A (en) | 1997-04-24 |
FI951979A (en) | 1995-06-29 |
WO1994010317A3 (en) | 1994-07-07 |
PL308555A1 (en) | 1995-08-21 |
JPH08505282A (en) | 1996-06-11 |
NO951629L (en) | 1995-07-03 |
AU689452B2 (en) | 1998-04-02 |
NO951629D0 (en) | 1995-04-28 |
RU2209247C2 (en) | 2003-07-27 |
PL177302B1 (en) | 1999-10-29 |
CA2146926A1 (en) | 1994-05-11 |
HU220198B (en) | 2001-11-28 |
FI951979A0 (en) | 1995-04-26 |
KR100349331B1 (en) | 2003-01-06 |
KR950704492A (en) | 1995-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0634459A3 (en) | Formulations. | |
AU6858391A (en) | Bundle tie | |
CZ197595A3 (en) | Vaccine preparations | |
ZA926733B (en) | 1,2-Dihydro-2-oxopyridines. | |
EP0604748A3 (en) | Trocar sleeve. | |
ZA938171B (en) | Conjugate vaccine against group B Streptococcus. | |
ZA937034B (en) | Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines | |
EP0572808A3 (en) | Antiblocage-system. | |
EP0468714A3 (en) | Peptide-polysaccharide-protein conjugate vaccines | |
ZA927999B (en) | Thickening agents. | |
EP0595970A4 (en) | Improved vaccine. | |
EP0584212A4 (en) | Liposomal polysaccharide vaccines. | |
EP0592354A3 (en) | Vacuum-centrifuge. | |
ZA933848B (en) | Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides | |
AU4970193A (en) | IPNV vaccine | |
GB9320943D0 (en) | Peptide-protein conjugate vaccines having anionic spacers | |
AU5626998A (en) | Conjugate vaccine against group B Streptococcus | |
ZA939564B (en) | Vaccines. | |
EP0681480A4 (en) | Recognin vaccines. | |
SG48106A1 (en) | Pneumococcal polyaccharide conjugate vaccine | |
ZA93236B (en) | Babesial rhoptry antigens. | |
EP0647139A4 (en) | ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR -i(HAEMOPHILUS INFLUENZAE). | |
ZA967198B (en) | Vaccines. | |
GB9108748D0 (en) | Conjugate | |
EP0644890A4 (en) | Oligonucleotide-polyamide conjugates. |